Literature DB >> 2201310

Autocrine growth factors and tumourigenic transformation.

R A Lang1, A W Burgess.   

Abstract

The development of tumours requires the simultaneous presence of a number of molecular perturbations. It is becoming increasingly clear that autocrine growth factor production, the topic of this review, is one such perturbation. Richard Lang and Antony Burgess summarize recent findings from a variety of in vitro and in vivo animal studies, and speculate on the possibilities for anti-growth factor therapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2201310     DOI: 10.1016/0167-5699(90)90098-t

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  16 in total

1.  Analysis of the fibroblast transformation potential of GTPase-deficient gip2 oncogenes.

Authors:  S K Gupta; C Gallego; J M Lowndes; C M Pleiman; C Sable; B J Eisfelder; G L Johnson
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

2.  Secretion of polypeptides related to epidermal growth factor and insulinlike growth factor I by a human teratocarcinoma cell line.

Authors:  N H Jing; R Shiurba; H Kitani; H Kawakatsu; Y Tomooka; T Sakakura
Journal:  In Vitro Cell Dev Biol       Date:  1991-11

3.  An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.

Authors:  J Chesney; C Metz; M Bacher; T Peng; A Meinhardt; R Bucala
Journal:  Mol Med       Date:  1999-03       Impact factor: 6.354

4.  The autonomous growth of human papillomavirus type 16-immortalized keratinocytes is related to the endothelin-1 autocrine loop.

Authors:  A Venuti; M L Marcante; S Flamini; V Di Castro; A Bagnato
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation.

Authors:  A L Witsell; L B Schook
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Constitutive activation of the interleukin 2 gene in the induction of spontaneous in vitro transformation and tumorigenicity of T cells.

Authors:  M Nagarkatti; M Hassuneh; A Seth; K Manickasundari; P S Nagarkatti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

7.  Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.

Authors:  M Schwabe; A T Brini; M C Bosco; F Rubboli; M Egawa; J Zhao; G L Princler; H F Kung
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop.

Authors:  R Burger; J Wendler; K Antoni; G Helm; J R Kalden; M Gramatzki
Journal:  Ann Hematol       Date:  1994-07       Impact factor: 3.673

9.  Malignant progression of B16 melanoma cells induced in vitro by growth factors produced by highly malignant cells.

Authors:  C W Stackpole; L Groszek; S S Kalbag
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

10.  Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

Authors:  T Blankenstein; Z H Qin; K Uberla; W Müller; H Rosen; H D Volk; T Diamantstein
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.